Seattle biotech startup Tune Therapeutics lands $175M to support clinical research Tune Therapeutics, a biotech company with headquarters in Seattle and Durham, N.C., raised $175 million in one of the largest… Read More
Juno’s lasting legacy: How the cell therapy juggernaut influenced biotech in Seattle and beyond When Juno Therapeutics launched in 2013, cell therapy was a nascent field. Early clinical studies were showing dramatic rates of… Read More
Tune Therapeutics launches with $40M in funding, aims to fine-tune activity of genes in cells A new biotech startup with operations in Seattle and Durham, N.C., has launched with $40 million in new funding and… Read More
